Introduction
============

Post-translational modification is an important mechanism for the regulation of protein function and stability. To date, more than 200 types of protein modification have been reported ([@B2]). One of these protein modifications, sumoylation, targets lysine for addition of a small ubiquitin-related modifier (SUMO; [@B51]). SUMO is a small peptide with a molecular mass of approximately 11 kDa. In yeast and animal systems, SUMO regulates various cellular processes such as stress and defense responses, nitrogen metabolism, hormone signaling, epigenetic gene expression, growth, and flowering ([@B14]; [@B25]; [@B27]; [@B37]; [@B36], [@B32]; [@B52]; [@B3]; [@B26]; [@B8]; [@B40]; [@B48]; [@B22]; [@B23]).

Although, conjugation of SUMO to target proteins can occur independently of ligases, modification of target proteins with SUMO is usually catalyzed by E3 SUMO ligases ([@B51]). The four types of E3 SUMO ligases identified to date are RanGAP1-binding protein 2 (RanBP2), polycomb group 2 (Pc2), non-SMC element/methyl methanesulfonate sensitive 1 (NES2/MMS21), and SAP and MIZ/protein inhibitor of activated STAT (SIZ/PIAS; [@B19]; [@B21]; [@B43]; [@B42]; [@B20]; [@B50]). PIAS/SIZ-type E3 SUMO ligase has five domains: SAP, PINIT, SP-RING finger, SXS, and PHD ([@B45]; [@B32]; [@B10]; [@B4]). To date, two PIAS-type SUMO E3 ligases, SIZ1 ([@B36], [@B32]) and High Ploidy 2 (HPY2; [@B15]; [@B16], [@B17]), have been reported in *Arabidopsis*.

AtSIZ1 is involved in nutrient assimilation, hormone signaling, growth, flowering, and stress responses ([@B36], [@B33], [@B31]; [@B52]; [@B3]; [@B26]; [@B10]; [@B18]; [@B35]; [@B40]; [@B48]; [@B22]; [@B23]). AtSIZ1 has several target proteins, including the nitrate reductases NIA1 and NIA2, INDUCER OF CBF EXPRESSION 1 (ICE1), the R2R3-type transcription factor MYB30, FLOWERING LOCUS C (FLC), SLEEPY1 (SLY1), and chromomethylase 3 (CMT3; [@B9]; [@B30]; [@B31]; [@B40]; [@B53]; [@B7]; [@B48]; [@B22]; [@B23]).

AtHPY2 is much smaller than AtSIZ1, comprising 249 amino acids and only a single domain (SP-RING zinc finger domain). Little is known about the role of HPY2, but studies suggest it is involved in regulating cell cycle progression, meristem development, and auxin signaling ([@B16]; [@B38]). AtSIZ1 and HPY2 exhibit different expression patterns, and their mutants display distinct dwarf phenotypes ([@B17]). In addition, their reciprocal expression does not complement the single-mutant phenotypes ([@B17]). To date, there have been no reports of sumoylation of specific target proteins by HPY2.

Flowering Locus C, a MADS-box transcription factor, participates in the control of flowering time ([@B44]; [@B47]). Expression of FLC is negatively regulated by components of the autonomous pathway and by vernalization ([@B29]; [@B46]; [@B12]; [@B24]; [@B11]), and *FLC* transcription is modulated by epigenetic methylation ([@B49]; [@B13]). Ubiquitination via E3 ubiquitin ligase activity of SINAT5 is thought to regulate FLC stability ([@B39]). FLC function and stability are also controlled by sumoylation, although the associated E3 SUMO ligase remains unidentified ([@B48]). These findings suggest that post-translational mechanisms are involved in the regulation of floral transition by FLC. However, although transcriptional control of *FLC* is relatively well-characterized, the mechanisms underlying post-translational modification of FLC remain unclear.

Here, we provide the first evidence that HPY2 functions as an E3 SUMO ligase for FLC, directly interacting with FLC to catalyze its sumoylation. Sumoylation stabilizes FLC, and loss of HPY2 causes early flowering. These findings indicate that HPY2 positively controls FLC-mediated flowering repression through FLC sumoylation.

Materials and Methods {#s1}
=====================

Plant Materials and Growth Conditions
-------------------------------------

Columbia-background ecotype *Arabidopsis thaliana* \[wild-type (WT)\] and the T-DNA insertion *hpy2-2* mutant were used in this study. To sterilize the seeds, WT and *hpy2-2* mutant seeds were treated with 5% sodium hypochlorite and 0.1% Triton X-100 for 10 min. For germination and growth in medium, the seeds were thoroughly washed with distilled water and then stored at 4°C in the dark. After 4 days, the seeds were plated on Murashige and Skoog (MS) agar medium including 2% sucrose. To prepare soil-grown plants, WT and *hpy2-2* mutant seeds were directly sown into vermiculite soil. Plants, including seedlings, were grown at 22°C under a 16 h light/8 h dark cycle (long day) or under an 8 h light/16 h dark cycle (short day) in a growth chamber.

Construction of Recombinant Plasmids
------------------------------------

To produce His~6~-FLC and GST-HPY2, full-length *FLC* and *HPY2* cDNAs were amplified by PCR and cloned into the pET28a (Novagen) and pGEX4T-1 (Amersham Biosciences) vectors, respectively. To prepare GST-FLC-Myc, full-length FLC cDNA was amplified using primers to add a Myc tag and cloned into pGEX4T-1. The FLC mutant proteins GST-FLCm1(K5R)-Myc, GST-FLCm2(K135R)-Myc, and GST-FLCm3(K154R)-Myc were prepared as previously described ([@B48]). Numbers indicate the positions of the lysine (K) residues, and R indicates replacement of lysine with arginine residues. For production of His~6~-AtSUMO1, *Arabidopsis* full-length *SUMO1* cDNA was amplified by PCR and cloned into pET28a. Primer sequences are described in Supplementary Table S1.

Purification of Recombinant Proteins
------------------------------------

All recombinant proteins were expressed in *Escherichia coli* strain BL21 and purified as previously described ([@B6]; [@B48]). Briefly, His~6~-AtSUMO1, His~6~-FLC, SUMO-activating enzyme E1 (His~6~-AtSAE1b and His~6~-AtSAE2), and SUMO-conjugating enzyme E2 (His~6~-AtSCE1) were purified with Ni^2+^-nitrilotriacetate (Ni^2+^-NTA) resins (Qiagen). GST, GST-FLC-Myc, GST-FLCm1(K5R)-Myc, GST-FLCm2(K135R)-Myc, GST-FLCm3(K154R)-Myc, and GST-HPY2 were purified with glutathione resins (Pharmacia).

*In Vitro* and *In Vivo* Interaction Assays
-------------------------------------------

*In vitro* pull-down assays to assess interactions between GST-HPY2 and His~6~-FLC were carried out using 2 μg each of GST-HPY2 bait and His~6~-FLC prey as previously described ([@B48]). His~6~-FLC was detected by Western blot analysis using anti-His antibody (Santa Cruz Biotechnology).

Plant expression plasmids were constructed to investigate the direct interaction between HPY2 and FLC *in vivo*. To express FLC, the corresponding full-length cDNA was amplified using a forward primer to add a hexameric Myc (Myc~6~) and a reverse primer and cloned into the pBA002 vector. To express HPY2, the corresponding full-length cDNA was amplified by PCR using a forward primer and a reverse primer to add a FLAG~3~ tag and cloned into the pBA002 vector. Hexameric Myc-tagged or trimeric FLAG-tagged primers were synthesized by DNA synthesizer (Bioneer). Wild-type *Arabidopsis* plants were infiltrated with different combinations of *Agrobacterium* transformed with *35S-Myc~6~-FLC* or *35S-HPY2-FLAG~3~* constructs. Total protein was extracted from each sample 2 days after infiltration, and Myc~6~-FLC and HPY2-FLAG~3~ were detected by Western blot analysis with anti-Myc and anti-FLAG antibodies, respectively. Finally, total protein was extracted from each sample and immunoprecipitated with anti-FLAG antibody (1 μg/mL, Santa Cruz Biotechnology) in a buffer containing 50 mM Tris-Cl (pH 8.0), 150 mM NaCl, 10% glycerol, 1% NP-40, 2 mM EDTA, 1 mM PMSF, and a protease inhibitor cocktail (Promega). FLC was detected in immunoprecipitated samples by Western blot analysis with anti-Myc antibody (0.5 mg/mL, Sigma-Aldrich).

Sumoylation Assays
------------------

*In vitro* sumoylation was performed in 30 μL of reaction buffer \[200 mM Hepes (pH 7.5), 5 mM MgCl~2~, 2 mM ATP\] with 50 ng of His~6~-AtSAE1b, 50 ng of His~6~-AtSAE2, 50 ng of His~6~-AtSCE1, 8 μg of His~6~-AtSUMO1, and 100 ng of GST-FLC-Myc, with or without 200 ng of GST-HPY2. After incubation for 3 h at 30°C, the reaction mixtures were separated on 11% SDS-PAGE gels. Sumoylated GST-FLC-Myc was detected by Western blot analysis using anti-Myc antibody (Santa Cruz Biotechnology). Sumoylation reactions were also performed as described above to identify the lysine residue modified by SUMO using WT FLC (GST-FLC-Myc) and mutant FLC \[GST-FLCm1(K5R)-Myc, GST-FLCm2(K135)-Myc, or GST-FLCm3(K154R)-Myc\].

Preparation of Single and Double Transgenic Plants
--------------------------------------------------

Flowering Locus C- or mFLC(K154R)-overexpressing plants were prepared by floral dipping as previously described ([@B5]; [@B48]). Double transgenic *Arabidopsis* plants overexpressing HPY2 and FLC or HPY2 and mFLC were produced by introduction of *XVE-HA~3~-HPY2* and *35S-FLC-FLAG~3~*, or *XVE-HA~3~-HPY2*, and *35S-mFLC-FLAG~3~*. Recombinant plasmid *XVE-HA~3~-HPY2* was generated by amplification of HPY2 cDNA with a forward primer tagged with trimeric HA~3~ (HA~3~) and a reverse primer, and insertion of the resultant fragment into the pET8 vector. Trimeric HA-tagged primers were synthesized by DNA synthesizer (Bioneer).

Examination of HPY2 Effect on FLC Stability *In Vivo*
-----------------------------------------------------

Two independent transgenic *35S-FLC-FLAG~3~* and *XVE HA~3~-HPY2* lines and two independent transgenic *35S-mFLC-FLAG~3~* and *XVE HA~3~-HPY2* lines were used for the experiment. Two-weeks-old double transgenic plants carrying *XVE HA~3~-HPY2* and *35S-FLC-FLAG~3~*, or *XVE HA~3~-HPY2*, and *35S-mFLC-FLAG~3~*, were treated with 10 μM β-estradiol. After 15 h, samples were ground in liquid nitrogen, and lysates were separated by 11% SDS-PAGE. FLC-FLAG~3~ and mFLC-FLAG~3~ levels were examined by Western blot analysis with anti-FLAG antibody. HA~3~-HPY2 induction was analyzed by Western blot analysis with anti-HA antibody.

Examination of Flowering Time in *hpy2-2* Mutants
-------------------------------------------------

Flowering time was investigated under long- and short-day conditions. WT and *hpy2-2* mutant plants were grown, and rosette leaves were counted when inflorescences appeared. Twenty plants of each type (WT or *hpy2-2* mutant) were used in the experiment.

Quantitative Real-time RT-PCR Analysis
--------------------------------------

Wild type and *hpy2-2* mutants were grown in long- and short-day conditions as described above. Total RNA was extracted from the leaves of WT and *hpy2-2* mutants, and quantitative real-time RT-PCR was used to assess transcript levels of *FLC*, *SUPPRESSOR OF OVEREXPRESSION OF CO 1* (*SOC1*), *FLOWERING LOCUS T* (*FT*), and *TWIN SISTER OF FT* (*TSF*) as described previously ([@B40]). Tubulin amplification was used as an internal control. All reactions were repeated three times. Primer sequences are listed in Supplementary Table S1.

Results
=======

FLC Interacts with HPY2 *In Vitro* and *In Vivo*
------------------------------------------------

Previous results showed that E3 SUMO ligase AtSIZ1 interacted with FLC to inhibit sumoylation ([@B48]). Here, we aimed to identify the E3 SUMO ligase that stimulated FLC sumoylation. HPY2, an *Arabidopsis* E3 SUMO ligase possessing an SP-RING (SIZ/PIAS-RING) domain, was chosen as a candidate. An *in vitro* pull-down assay was used to examine the interaction of HPY2 with FLC. Recombinant proteins GST-HPY2 and His~6~-FLC were overexpressed in *E. coli* and purified with glutathione or Ni^2+^-NTA resins (**Figure [1A](#F1){ref-type="fig"}**). The results showed that GST-HPY2 was able to pull down His~6~-FLC (**Figure [1B](#F1){ref-type="fig"}**). The interaction between HPY2 and FLC was also examined by immunoprecipitation (IP). Two constructs, *35S-Myc~6~-FLC* and *35S-HPY2-FLAG~3~*, were coinfiltrated into the leaves of WT plants. After IP with anti-FLAG antibody, Myc~6~-FLC was examined by Western blot analysis using anti-Myc antibody. Myc~6~-FLC was clearly detected (**Figure [1C](#F1){ref-type="fig"}**), indicating a strong interaction between HPY2 and FLC, consistent with the results of the *in vitro* pull-down experiment.

![**Interaction of HPY2 with FLC.** **(A)** His~6~-FLC and GST-HPY2 were overexpressed in *Escherichia coli* and purified with Ni^2+^-NTA or glutathione affinity columns. **(B)** The His~6~-FLC protein was pulled down with the GST-HPY2 protein, separated on 11% SDS-polyacrylamide gels, and analyzed by Western blotting with anti-His antibody. **(C)** *In vivo* interaction of HPY2 and FLC. Wild-type (WT) plants were infiltrated with different combinations of *35S-Myc~6~-FLC* or *35S-HPY2-FLAG~3~* constructs. Total protein was extracted from each sample and immunoprecipitated with anti-FLAG antibody. After immunoprecipitation, Myc~6~-FLC was detected by Western blotting with anti-Myc antibody. Myc~6~-FLC and HPY2-FLAG~3~ expression was also examined by Western blotting with anti-Myc and anti-FLAG antibodies, respectively.](fpls-07-00530-g001){#F1}

FLC Sumoylation Is Stimulated by HPY2
-------------------------------------

The strong interaction between HPY2 and FLC (**Figures [1B,C](#F1){ref-type="fig"}**) suggested that FLC could be modified by SUMO through E3 SUMO ligase activity of HPY2. Therefore, we next tested whether HPY2 had E3 SUMO ligase activity for FLC. *In vitro* sumoylation reactions were performed using His~6~-AtSAE1b, His~6~-AtSAE2, His~6~-AtSCE1, His~6~-AtSUMO1, GST-HPY2, and GST-FLC-Myc. The amount of sumoylated GST-FLC-Myc was increased by HPY2 in an E1- and E2-dependent manner (**Figure [2A](#F2){ref-type="fig"}**).

![**Flowering Locus C (FLC) is sumoylated by HPY2 *in vitro*.** *Arabidopsis* His~6~-AtSAE1b, His~6~-AtSAE2, His~6~-AtSCE1, GST-HPY2, His~6~-AtSUMO1, and GST-FLC-Myc were overexpressed in *E. coli* and purified with Ni^2+^-NTA or glutathione affinity columns as appropriate. **(A)** Sumoylation of GST-FLC-Myc was assayed in the presence or absence of E1 (His~6~-AtSAE1b and His~6~-AtSAE2), E2 (His~6~-AtSCE1), E3 (GST-HPY2), and His~6~-AtSUMO1. FLC sumoylation was detected by Western blotting with anti-Myc antibody. **(B)** To identify the sumoylation site on FLC, GST-FLCm1-Myc (K54R), GST-FLCm2-Myc (K135R), and GST-FLCm3-Myc (K154R) were overexpressed in *E. coli* and purified using a glutathione affinity column. The reaction mixture contained E1 (His~6~-AtSAE1b and His~6~-AtSAE2), E2 (His~6~-AtSCE1), E3 (GST-HPY2), and His~6~-AtSUMO1 without (-) or with (+) a mutant protein instead of GST-FLC-Myc. FLC sumoylation was detected by Western blotting with anti-Myc antibody.](fpls-07-00530-g002){#F2}

Our previous study showed that FLC contained three possible sumoylation sites ([@B48]). Single- or double-mutant derivatives with the mutations K154R, K5R/K135R, K5R/K154R, or K135R/K154R were produced, and their sumoylation was examined by *in vitro* sumoylation assays ([@B48]). The results showed K154 to be the principal site of SUMO conjugation on FLC ([@B48]). In the current study, HPY2-mediated sumoylation was examined in the mutant FLC proteins GST-FLCm1(K5R)-Myc, GST-FLCm2(K135)-Myc, and GST-FLCm3(K154R)-Myc. Consistent with the previous study, GST-FLCm3(K154R)-Myc was not sumoylated, even in the presence of HPY2, confirming that the lysine residue at position 154 was a true sumoylation site (**Figure [2B](#F2){ref-type="fig"}**).

HPY2 Stabilizes FLC
-------------------

Based on the strong interaction of HPY2 with FLC and the increase in FLC sumoylation as a result of HPY2 activity, we inferred that FLC stability could be modulated by HPY2. We therefore measured the effect of HPY2 on FLC levels using double transgenic plants with *XVE-HA~3~-HPY2* and *35S-FLC-FLAG~3~* or with *XVE-HA~3~-HPY2* and *35S-mFLC-FLAG~3~*. In mFLC, the lysine at position 154 (sumoylation site) was mutated to arginine (K154R). *HPY2* induction increased FLC levels by up to 2.3- and 3.6-fold in two independent transgenic plants (**Figures [3A,C](#F3){ref-type="fig"}**). However, no increase in mFLC level was seen after induction of *HPY2* in two independent transgenic plants (**Figures [3B,C](#F3){ref-type="fig"}**). *FLC* and *mFLC* transcript levels were similar after induction of *HPY2* expression, as determined using real-time qRT-PCR (**Figures [3A,B](#F3){ref-type="fig"}**). These data indicate that the FLC protein is stabilized by the E3 SUMO ligase activity of HPY2.

![**Flowering Locus C is stabilized by HPY2 *in vivo*.** Double transgenic plants containing *35S-FLC-FLAG~3~* and *XVE-HA~3~-HPY2* **(A)** or *35S-mFLC (K154R)-FLAG~3~* and *XVE-HA~3~-AtSIZ1* **(B)** were incubated in liquid medium with β-estradiol to induce *HPY2* expression. After incubation for 15 h, HA~3~-HPY2, FLC-FLAG~3~, and mFLC-FLAG~3~ levels were assessed by Western blotting with anti-HA or anti-FLAG antibodies. Tubulin was used as a loading control. Numbers under lanes indicate relative intensities. Protein levels were normalized to a value of 1.00 for FLC or mFLC levels without inducer ("--" in both panels). RNA concentrations of *FLC-FLAG~3~* and *mFLC-FLAG~3~* were determined by real-time qRT-PCR using a FLAG primer and a gene-specific primer. *Tubulin* RNA was used as a loading control. **(C)** Graphical expression of *Tubulin*, *FLC-FLAG~3~*, and *mFLC-FLAG~3~* transcript levels from **(B)**. Bars indicate standard errors (*n* = 3).](fpls-07-00530-g003){#F3}

A *hpy2* Mutant Exhibits Early Flowering
----------------------------------------

Flowering Locus C is stabilized by HPY2-mediated sumoylation, suggesting that FLC functions may be compromised in a *hpy2* mutant background and that flowering may be affected. Two independent T-DNA insertion mutant lines, *hpy2-1* and *hpy2-2*, were characterized previously ([@B16], [@B17]). The *hpy2-2* mutant exhibits a relatively weak phenotype, but the *hpy2-1* mutant shows a severe growth defect phenotype and growth frequently stops prior to bolting. The *hpy2-2* mutant was therefore chosen to examine flowering time. Rosette leaves were counted just after bolting in WT and *hpy2-2* plants. Compared to WT, flowering was delayed in *hpy2-2* mutants under both long- and short-day conditions (**Figures [4A,B](#F4){ref-type="fig"}**). Flowering delay in *hpy2-2* was significant under short-day conditions but was less pronounced under long-day conditions (**Figures [4A,B](#F4){ref-type="fig"}**).

![**Flowering time of *hpy2-2* mutants.** Early flowering was observed in the *hpy2-2* mutant grown under both long- and short-day conditions **(A)**. Flowering time was investigated by counting the number of rosette leaves present when inflorescences appeared **(B)**. The number of rosettes in WT and *hpy2-2* plants differed significantly (^∗∗∗^*P* \< 0.0001, *t*-test, *n* = 20). Bars indicate standard errors.](fpls-07-00530-g004){#F4}

Expression of Flowering-related Genes Is Affected by HPY2
---------------------------------------------------------

HPY2 was identified as an E3 SUMO ligase for FLC, suggesting that the early flowering phenotype seen in *hpy2-2* mutants might be partly caused by low levels of FLC and decreased FLC activity. However, it was also possible that early flowering in *hpy2-2* mutants occurred as a consequence of altered gene expression. To investigate this, real-time qRT-PCR was used to measure transcript levels of *FLC* and the flowering-related genes *SOC1*, *FT*, and *TSF* in WT and *hpy2-2* mutants grown in long- or short-day conditions (**Figures [5A,B](#F5){ref-type="fig"}**). *SOC1*, *FT*, and *TSF* were slightly upregulated in *hpy2-2* mutants compared with their expression in WT plants under long-day conditions (**Figure [5A](#F5){ref-type="fig"}**). More substantial differences in the expression of *SOC1*, *FT*, and *TSF* were apparent under short-day conditions, with approximately twofold higher transcript levels observed in *hpy2-2* plants compared to WT plants (**Figure [5B](#F5){ref-type="fig"}**).

![**Transcript levels of flowering-related genes in *hpy2-2* mutants.** Total RNA was isolated from the leaves of WT and *hpy2-2* mutant plants grown in soil under long **(A)**-or short-day **(B)** conditions. Transcript levels were examined using real-time qRT-PCR with gene-specific primers. Results are expressed as the mean ± SD (*n* = 3). *FLC*, *FLOWERING LOCUS C*; *SOC1*, *SUPPRESSOR OF OVEREXPRESSION OF CO 1*; *FT*, *FLOWERING LOCUS T*; *TSF*, *TWIN SISTER OF FT*.](fpls-07-00530-g005){#F5}

Discussion
==========

In this study, HPY2 was shown to be a functional E3 SUMO ligase that was able to directly interact with FLC to catalyze its sumoylation.

To date, two SIZ-type E3 SUMO ligases have been identified in plants, namely, AtSIZ1 and HPY2. The functional roles and phenotypic features of AtSIZ1 are well-characterized. However, the functions of HPY2 are poorly understood. A recent study showed that HPY2 had self-sumoylation activity *in vitro*, and that mutation of HPY2 reduced SUMO-conjugate levels in *Arabidopsis* ([@B16]). In addition, loss of HPY2 function resulted in a premature mitotic-to-endocytic transition that led to severe dwarfism ([@B16]). Whereas the phenotype of *hpy2-1* mutants did not depend on the accumulation of salicylic acid (SA), the *siz1-2* mutant phenotype was caused by SA accumulation, indicating that the two proteins functioned through different pathways and that their roles did not overlap ([@B17]).

Sumoylation of target proteins by AtSIZ1 is well-characterized ([@B9]; [@B30]; [@B31]; [@B40]; [@B53]; [@B7]; [@B48]; [@B22]; [@B23]). However, the targets of HPY2 remain unidentified, and E3 ligase activity of HPY2 against target proteins has not been reported to date. In a previous study, we showed that AtSIZ1 interacts directly with FLC and stabilizes the protein ([@B23]). However, our results showed that AtSIZ1 inhibited FLC sumoylation, which led us to speculate that HPY2 may act as a specific E3 SUMO ligase for FLC. An *in vitro* sumoylation assay showed that HPY2 had E3 SUMO ligase activity against FLC through direct interaction (**Figures [1B,C](#F1){ref-type="fig"}** and **[2A](#F2){ref-type="fig"}**). This is the first report demonstrating HPY2 E3 SUMO ligase activity for a target protein.

Modification of target lysines by SUMO occurs by two different mechanisms. In the first mechanism, target proteins are directly modified by conjugating enzyme E2 ([@B1]; [@B28]; [@B54]). The second mechanism involves E3 ligase-mediated sumoylation ([@B41]). Our previous study showed that FLC could be sumoylated without the help of an E3 SUMO ligase, and that FLC sumoylation was inhibited by the E3 SUMO ligase AtSIZ1. In the present study, we found that the level of sumoylated FLC was increased by the addition of HPY2 (**Figure [2A](#F2){ref-type="fig"}**), indicating that FLC sumoylation was stimulated by HPY2 via its E3 SUMO ligase activity.

Our previous study showed that AtSIZ1 inhibited FLC sumoylation but stabilized the FLC protein ([@B48]). In the current study, HPY2 overexpression led to an increase in levels of FLC but not in levels of mFLC, which lacked the critical lysine residue for sumoylation (**Figures [3A--C](#F3){ref-type="fig"}**), indicating that FLC sumoylation by HPY2 stabilized FLC. In yeast, animal, and plant systems, modification by SUMO affects the stability and activity of target proteins ([@B41]). Consistent with this, our results showed that sumoylation had a positive effect on FLC function.

Since FLC is a central regulator of flowering and HPY2 has E3 SUMO ligase activity against FLC, we next examined flowering time in the *hpy2-2* mutant. Mutant plants flowered earlier than WT plants (**Figure [4](#F4){ref-type="fig"}**). Previously, we reported that flowering time was significantly delayed by the overexpression of WT *FLC* but that flowering time was unaffected by overexpression of *mFLC* ([@B48]), indicating that sumoylation was critical for the floral repressor function of FLC. This suggests that early flowering in *hpy2-2* mutants is caused by the reduced stability and lower activity of FLC resulting from the loss of HPY2 E3 SUMO ligase activity.

Our data suggest that early flowering in the *hpy2-2* mutant results from the loss of HPY2 activity, which leads to low FLC levels or low FLC activity. However, it was possible that early flowering of the *hpy2-2* mutant might be a consequence of changes in gene expression. *FLC* transcript levels were decreased in the *hpy2-2* mutant (**Figure [5](#F5){ref-type="fig"}**) indicating that HPY2 regulated FLC-mediated flowering at the transcriptional level as well as at the post-translational level.

Conclusion
==========

HPY2 controls FLC-mediated floral transition through its E3 SUMO ligase activity as well as through direct binding to FLC. Taken together with previous findings, our data indicate that two E3 SUMO ligases, AtSIZ1 and HPY2, are involved in the regulation of FLC stability, and that sumoylation is a critical modification for the regulation of FLC function. Elucidation of the mechanisms underlying the regulation of FLC function by AtSIZ1 and HPY2, alone or in combination, will enhance our understanding of the modulation of flowering time by the SUMO system.
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